相关实验视频

Updated: Jul 9, 2025

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Published on: November 18, 2019

卵巢癌中菌基因:为改善免疫疗法进行全面分析

Wenting He¹, Jieping Chen¹, Yun Zhou¹

¹Department of Gynecologic Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.

Discover oncology

|December 1, 2023

概括

与髓相关的基因 (MRG) 影响卵巢癌 (OV) 的进展. 一个新的MRG得分预测了更好的生存率和治疗敏感性,为免疫疗法和化疗提供了洞察力.

科学领域:

线粒体生物学线粒体生物学
癌症研究癌症研究
免疫学免疫学免疫学

背景情况:

线粒体,受损线粒体的选择性降解,与免疫和癌症有关.
在卵巢癌 (OV) 瘤微环境 (TME) 中,与线粒细胞衰变相关的基因 (MRG) 的作用尚不清楚.

研究的目的:

调查MRG在OV TME中的作用.
开发基于MRG的OV的预后生物标志物.

主要方法:

在480个OV样本中分析了29个MRG,包括表达,预后和遗传变化.
无监督聚类以根据MRG表达方式将OV分类为亚型.
为预测整体存活率,构建和验证一个线粒分数系统 (MRG_score).

主要成果:

高MRG_score与改善患者存活率和增加免疫细胞透率相关.
具有高MRG_score的患者可能对免疫检查点抑制剂 (ICI) 治疗有更好的反应.
该MRG_score预测了对化疗和向抑制剂的敏感性.

结论:

该MRG_score作为一个潜在的预后生物标志物和治疗预测器在OV.
这项研究强调了MRG在OV TME中的重要性,并确定了针对特定疗法的患者子组.
研究结果表明,ICI,化疗或向治疗对具有高MRG分数的患者有潜在的益处.

关键词:

免疫学免疫学免疫学在MRG_score中使用MRG_score 线粒细胞衰变 (mitophagy) 是一种卵巢癌是发生在卵巢中的癌症.瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.